HTRA2 and neuroblastoma: Protease Omi facilitates neurite outgrowth by cleaving the transcription factor E2F1 in neuroblastoma cells, which is abolished by pretreatment with the specific Omi inhibitor UCF-101 (Ma et al. 2015).